Randip Kaur
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 7
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Yvonne Perrie (13 shared papers)Alexander Wilkinson (2 shared papers)Elisabeth Kastner (2 shared papers)Vincent W. Bramwell (3 shared papers)Daniel J. Kirby (4 shared papers)Deborah Lowry (1 shared paper)Malou Henriksen‐Lacey (3 shared papers)Jitinder S. Wilkhu (2 shared papers)
- Journals
- Journal of Controlled Release (2 papers)International Journal of Pharmaceutics (2 papers)Molecular Pharmaceutics (1 paper)Human Vaccines & Immunotherapeutics (1 paper)PLoS ONE (1 paper)
- Partner nations
- United KingdomDenmarkSpain
In The Last Decade
Randip Kaur
13 papers receiving 542 citations
Peers
Comparison fields: 5 of 54
- Biomaterials 214
- Pharmaceutical Science 103
- Immunology 169
- Drug Discovery 2
- Biomedical Engineering 91
Countries citing papers authored by Randip Kaur
This map shows the geographic impact of Randip Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randip Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randip Kaur more than expected).
Fields of papers citing papers by Randip Kaur
This network shows the impact of papers produced by Randip Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randip Kaur. The network helps show where Randip Kaur may publish in the future.
Co-authors
The 25 scholars most cited alongside Randip Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 161 | |
| 2 | 2010 | 120 | |
| 3 | 2011 | 61 | |
| 4 | 2012 | 51 | |
| 5 | 2012 | 45 | |
| 6 | 2013 | 42 | |
| 7 | 2013 | 34 | |
| 8 | 2016 | 14 | |
| 9 | 2011 | 13 | |
| 10 | 2013 | 9 | |
| 11 | 2009 | 7 | |
| 12 | 2012 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2013 | 0 |
About Randip Kaur
Randip Kaur is a scholar working on Immunology, Biomaterials, Pharmaceutical Science, Biomedical Engineering and Infectious Diseases, having authored 14 papers that have together received 559 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Nanoparticle-Based Drug Delivery (3 papers), Lipid Membrane Structure and Behavior (2 papers), Advanced Drug Delivery Systems (2 papers), Ultrasound and Hyperthermia Applications (1 paper), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper), Hepatitis B Virus Studies (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Biomaterials (214 citations), Pharmaceutical Science (103 citations), Immunology (169 citations), Drug Discovery (2 citations) and Biomedical Engineering (91 citations). Randip Kaur has collaborated with scholars based in United Kingdom, Denmark and Spain. Frequent co-authors include Yvonne Perrie, Alexander Wilkinson, Elisabeth Kastner, Vincent W. Bramwell, Daniel J. Kirby, Deborah Lowry, Malou Henriksen‐Lacey, Jitinder S. Wilkhu, Dennis Christensen and Sagida Bibi. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Molecular Pharmaceutics, Human Vaccines & Immunotherapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.